Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells
Authors
Keywords
-
Journal
Cancer Medicine
Volume 6, Issue 11, Pages 2646-2659
Publisher
Wiley
Online
2017-09-28
DOI
10.1002/cam4.1179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Δ40p53α suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells
- (2016) Akinobu Ota et al. JOURNAL OF CELL SCIENCE
- Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells
- (2015) Shuhei Hakiri et al. CANCER SCIENCE
- Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma
- (2014) Anthony W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Whole-Exome Sequencing Reveals Frequent Genetic Alterations in BAP1, NF2, CDKN2A, and CUL1 in Malignant Pleural Mesothelioma
- (2014) G. Guo et al. CANCER RESEARCH
- Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells
- (2014) Toshiki Nakaoka et al. CELLULAR ONCOLOGY
- Evaluation and Clinical Analyses of Downstream Targets of the Akt Inhibitor GDC-0068
- (2013) Y. Yan et al. CLINICAL CANCER RESEARCH
- The Paradox of Akt-mTOR Interactions
- (2013) Lakshmipathi Vadlakonda et al. Frontiers in Oncology
- Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study
- (2012) Andrzej J. Jakubowiak et al. BRITISH JOURNAL OF HAEMATOLOGY
- Arsenic trioxide prevents nitric oxide production in lipopolysaccharide -stimulated RAW 264.7 by inhibiting a TRIF-dependent pathway
- (2012) Miyuki Takahashi et al. CANCER SCIENCE
- Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background
- (2012) B. R. Davies et al. MOLECULAR CANCER THERAPEUTICS
- YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes
- (2012) T Mizuno et al. ONCOGENE
- Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma
- (2012) Giulia Pinton et al. PLoS One
- Update on Malignant Pleural Mesothelioma
- (2011) Nicholas Campbell et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
- (2010) Todd W. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Malignant Pleural Mesothelioma: A Population-Based Study of Survival
- (2010) Michael T. Milano et al. Journal of Thoracic Oncology
- FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
- (2009) Huadong Pei et al. CANCER CELL
- Inhibitor hijacking of Akt activation
- (2009) Tatsuya Okuzumi et al. Nature Chemical Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation